跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,035 条关于
“TRB-ILD1”
全部
2,035
临床试验
1,442
药物
420
机构
23
资讯
150
11个月前
Transpire Bio Receives FDA Orphan Drug Designation for Inhaled Therapies Targeting IPF and Glioblastoma
11个月前
US Orphan Drug Market Poised to Exceed $190 Billion by 2030 as FDA Designations Accelerate Rare Disease Therapy Development
去年
TRexBio Initiates First-in-Human Trial of TRB-061, Novel TNFR2 Agonist for Atopic Dermatitis
去年
TRexBio Secures $84 Million in Series B Funding to Advance TNFR2 Agonist TRB-061
去年
EBV-Specific Immune Response Distinct in Multiple Sclerosis Compared to Other Demyelinating Diseases
7个月前
TRexBio Secures $50M to Advance Novel Regulatory T Cell Therapy for Atopic Dermatitis
去年
TRex Bio Secures $84 Million to Advance Treg-Activating Therapies for Immune Disorders
去年
TRBC1-CAR T Cell Therapy Shows Promise in Peripheral T Cell Lymphoma
去年
EMA Recommends Ofev for Progressive Fibrosing ILDs in Children and Adolescents
2年前
Phase 2 Trial Assesses 99mTc-maraciclatide for ILD Prognosis
第 1 页,共 15 页
上一页
下一页